The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
UNICAB: Cabozantinib in locally advanced or metastatic non‐clear cell renal cell carcinoma post immunotherapy or in those unsuitable for immunotherapy (ANZUP 1802).
 
David William Pook
Honoraria - Bayer; Merck/Pfizer
Consulting or Advisory Role - Astellas Pharma; Bristol Myers Squibb Foundation; Bristol-Myers Squibb; Bristol-Myers Squibb; Cipla; Merck; Merck Sharp & Dohme; Merck Sharp & Dohme (Inst); Merck/Pfizer; Merck/Pfizer; Pfizer; Pfizer (Inst)
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche (Inst); SymVivo (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Astellas Pharma; Bristol-Myers Squibb; Janssen; Merck/Pfizer; Merck/Pfizer; Pfizer
 
Carole A. Harris
Consulting or Advisory Role - Astellas Pharma (Inst); BMS (Inst); Merck (Inst); MSD (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Emma Link
Patents, Royalties, Other Intellectual Property - Emma is an innovator: the discovery of her DPhil has been the subject of patent applications in the USA, UK, Europe, China, and Japan. The US rights to the patent were granted to Boston Heart Diagnostics which optimised the test on their technology platfo
 
Jeffrey C. Goh
Stock and Other Ownership Interests - ICON Cancer Care; Immutep
Honoraria - AstraZeneca; MSD Oncology
Consulting or Advisory Role - BMS; GlaxoSmithKline; Janssen Oncology; MSD
Speakers' Bureau - AstraZeneca/MedImmune; Eisai; Ipsen; Janssen; MSD Oncology; Pfizer/EMD Serono
Travel, Accommodations, Expenses - Bayer; Pfizer/EMD Serono
 
Francis Parnis
Stock and Other Ownership Interests - Telix Pharmaceuticals
Consulting or Advisory Role - Ipsen; Janssen Oncology; Merck Serono
Speakers' Bureau - AstraZeneca
Other Relationship - Bayer Schering Pharma
 
Howard Gurney
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Merck Serono; Merck Sharp & Dohme; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Merck Serono
 
Ganessan Kichenadasse
No Relationships to Disclose
 
Craig Underhill
Consulting or Advisory Role - AstraZeneca; Bayer; Merck Serono
Speakers' Bureau - AstraZeneca; IQvia
Research Funding - Akeso Biopharma (Inst); Arcus Biosciences (Inst); AtriCure (Inst); BeyondSpring Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Deciphera (Inst); novotech (Inst)
 
Javier Torres
No Relationships to Disclose
 
Felicia Roncolato
No Relationships to Disclose
 
Andrisha Jade Inderjeeth
Honoraria - BMS; Pfizer
 
Ciara Conduit
Honoraria - AstraZeneca; Janssen
Travel, Accommodations, Expenses - Merck
 
Margaret Mary McJannett
Employment - Anzup
 
Ian D. Davis
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Ipsen (Inst); Janssen Oncology (Inst); Medivation (Inst); Movember Foundation (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - International Patent Application No: PCT /US2004/032147 (NY-ESO-1) through Ludwig Institute for Cancer Research.
 
Craig Gedye
Consulting or Advisory Role - BCAL Diagnostics; Bristol-Myers Squibb (Inst); CADEX Genomics; Merck Sharp & Dohme (Inst); Novotech
Speakers' Bureau - Limbic Oncology (Inst)